Ms Vairavan is the vice president, finance and corporate controller, where she is responsible for overseeing daily accounting operations, ensuring compliance with financial, accounting, and income tax regulations, all investor relations activities, and overseeing financial planning and analysis. She joined Arcutis in 2020 and previously held positions as vice president of finance and investor relations and executive director, financial planning and analysis. Previously, Ms Vairavan was at Amgen for over 15 years, where she held various roles of increasing responsibility within the finance organization, culminating as finance director for US value and access, where she modeled the impact of reimbursement policy changes and liaised with state government affairs teams on various state related drug pricing requirements. Ms Vairavan started her career as a financial consultant working for KPMG and Arthur Andersen. She holds a BS in Business Administration, Finance, from the University of Southern California, and is a licensed CPA in California.

Kent Taylor joined Arcutis in November 2023 as vice president, sales and was promoted to senior vice president, sales in December 2024. Mr Taylor is a commercial executive with over 25 years of marketing and sales leadership experience in the pharmaceutical industry. He has a proven track record of building commercial infrastructures, delivering successful product launches, life cycle management, and executing comprehensive strategies to drive profitable growth. Most recently, Mr Taylor was the vice president of sales, dermatology at Incyte. Prior to Incyte, his experience includes being the head of sales and marketing at Encore Dermatology, the group director of the Dermatology Atopic Dermatitis franchise at Onset Dermatologics, and the associate director of US and Canada Immune franchise at Medicis. Prior to his time at Medicis, Mr Taylor worked for 3M in Dermatology, OBGYN, Infectious Disease, and other specialty markets, where he held numerous roles that included US product manager, US speaker development manager, and medical science and education liaison. At 3M he also spent over two years as a Six Sigma Black Belt, managing key strategic and critical business projects within the Skin and Wound Care, Infection Prevention, and Food Safety divisions. Mr Taylor has also held various sales positions at Allergan Therapeutics, Wyeth-Ayerst Laboratories, and General Medical Corporation. Mr Taylor holds a BS in Marketing from the University of Arizona.

Mr Edwards joined Arcutis in September 2023 as chief commercial officer and is responsible for overseeing and managing all commercial operations for Arcutis.  Mr Edwards brings over 25 years of sales, market access, marketing, and general management experience.  Prior to joining Arcutis, he spent almost three years at Incyte as group vice president and business unit head of immunology where he led the successful launch and commercialization of their topical JAK inhibitor for atopic dermatitis.  Prior to that Mr Edwards was at UCB for nearly eight years as the head of US immunology and later head of global immunology operations and strategy, where he was instrumental in leading commercialization of their dermatology, rheumatology, and gastroenterology portfolios.  Prior to that, he held senior roles at AbbVie and TAP Pharmaceuticals.  Mr Edwards holds a BS from East Tennessee State University and an MBA from Embry-Riddle Aeronautical University. He is also a decorated veteran of the US Army.

Dr Snyder joined Arcutis in 2020 leading Patient Safety & Pharmacovigilance. Prior to joining us, Dr Snyder supported Safety Evaluation and Risk Management at Intercept Pharmaceuticals. Prior to this role, Dr. Snyder was at AbbVie where he lead many of the Safety Science activities for medical dermatology products on the market and in clinical development. He also supported the regulatory approval of an additional orphan indication for the treatment of a dermatologic condition in the US and Canada while working in Regulatory Affairs. During his tenure at AbbVie, Dr Snyder supported benefit-risk analyses in the oncology, infectious disease, and general medicine therapeutic areas. Dr Snyder earned his PharmD from Midwestern University’s Chicago College of Pharmacy and subsequently a MS in Biomedical Informatics at University of Chicago.

Mr Tucker is the chief human resources officer at Arcutis, where he leads the growth and development of Arcutis’ team and ensures a world-class corporate culture. He joined the company in July 2020 as executive director of HR.  Prior to Arcutis, Mr Tucker was the senior director of total rewards at Atara Biotherapeutics, where he led the compensation and benefits department. Prior to Atara, Mr Tucker was the senior director and head of human resources at Sienna Biopharmaceuticals, where he established and led the human resources function as the company transitioned from a private to a publicly traded company. Prior to Sienna, Mr Tucker was the associate director of human resources at Kythera. In his role at Kythera he was instrumental in building out the sales force for the company’s launch of Kybella®. He has also held roles in non-profit management where he oversaw all administrative functions, including human resources, information technology, bookkeeping, budgeting, and facilities. Mr Tucker started his career in Amgen’s human resources department, where he held roles of increasing responsibility. He earned a bachelor’s degree in business administration, with an option in human resource management, from California State University, Northridge.

Mr Matsuda joined Arcutis in January 2022 as general counsel and corporate secretary. He is responsible for all legal and compliance for the company, as well as serving as secretary of the board of directors. Mr Matsuda previously served as senior vice president, general counsel, chief compliance officer, and corporate secretary at Halozyme Therapeutics, Inc. Prior to Halozyme, Mr Matsuda worked at Amgen for 18 years in positions of increasing responsibility with his last role serving as vice president, Law, Global Commercial Operations, where he was responsible for strategic commercial legal support to the US Commercial Operations organization, as well as Medical Affairs, Compliance, Global Value, Access & Policy, Global Marketing, and Biosimilars divisions. Mr Matsuda received a Bachelor of Science in Business Administration with a dual emphasis in Corporate Finance and International Finance from the University of Southern California, and a Juris Doctorate from University of California, Hastings College of the Law.

Mr Madan brings over 20 years of digital transformation and innovation experience to the Arcutis team. Prior to joining Arcutis, Mr Madan served as the vice president of digital, data/analytics and innovation for consumer healthcare technology at GlaxoSmithKline (GSK), where, in partnership with the chief digital officer, he was responsible for driving significant elements of their digital and tech transformation globally. Before GSK, Mr Madan was with Novartis where he was responsible for managing and delivering global, regional, and localized digital solutions and services across 3 business units and in more than 80 countries. In addition to healthcare, Mr Madan has experience in the consumer goods sector, having spent 14 years at L’Oreal in various roles, including managing the digital tech function for L’Oreal Americas. Mr Madan holds a bachelor’s degree in computer engineering from the New Jersey Institute of Technology and master’s degrees in both business administration and information systems from New York University Stern School of Business.

Ms Barton joined Arcutis in February 2021 as chief compliance officer, bringing over 17 years of corporate and healthcare compliance experience to our growing team. Prior to joining Arcutis, Ms Barton served as vice president, commercial excellence & chief compliance officer at Cipla Therapeutics, a division of Cipla, USA. Ms Barton has broad, global compliance and ethics expertise, having begun her compliance and ethics career at Winn-Dixie Stores, Incorporated before transitioning to roles in the pharmaceutical and medical device sector with Bausch + Lomb, Allergan, Kythera, Anacor, and MannKind Corporation. She has also held positions with Merrill Lynch and Janus, including an appointment overseas. A graduate of Syracuse University, Ms Barton holds bachelor’s degrees in political science and international relations, both magna cum laude, and is a Certified Compliance and Ethics Professional (CCEP) and Certified Information Privacy Professional (CIPP US/E).